Bosh sahifaGUD • TSE
add
Knight Therapeutics Inc
Yopilish kursi
5,92 $
Kunlik diapazon
5,88 $ - 6,03 $
Yillik diapazon
5,11 $ - 6,55 $
Bozor kapitalizatsiyasi
598,54 mln CAD
Oʻrtacha hajm
50,03 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
TSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 121,55 mln | 31,74% |
Joriy xarajat | 55,16 mln | 31,93% |
Sof foyda | -3,79 mln | -4 560,00% |
Sof foyda marjasi | -3,12 | -3 566,67% |
Har bir ulushga tushum | -0,02 | — |
EBITDA | 18,41 mln | 10,98% |
Amaldagi soliq stavkasi | -97,76% | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 118,14 mln | -31,44% |
Jami aktivlari | 1,05 mlrd | 8,97% |
Jami passivlari | 281,78 mln | 49,58% |
Umumiy kapital | 766,79 mln | — |
Tarqatilgan aksiyalar | 99,29 mln | — |
Narxi/balansdagi bahosi | 0,77 | — |
Aktivlardan daromad | 0,15% | — |
Kapitaldan daromad | 0,19% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -3,79 mln | -4 560,00% |
Operatsiyalardan naqd pul | 10,16 mln | 102,61% |
Sarmoyadan naqd pul | -1,41 mln | -112,20% |
Moliyadan naqd pul | -5,91 mln | -50,47% |
Naqd pulning sof oʻzgarishi | 4,06 mln | -68,64% |
Boʻsh pul | -3,92 mln | -484,53% |
Haqida
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Tashkil etilgan
2014
Bosh ofis
Sayt
Xodimlar soni
745
